This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Murray Cohen, MD; Itzhak Kronzon, MD; Arthur Lebowitz, MD

Arch Intern Med. 1982;142(8):1570-1571.

Abstract
Doxorubicin hydrochloride is a chemotherapeutic agent highly effective against a wide range of neoplasms. A prime limiting factor to the administration of this drug is cardiotoxicity, which frequently develops when the cumulative dose exceeds 500 mg/sq m. Late cardiomyopathy, which may develop up to a year after therapy has been discontinued, was thought to be rapidly progressive and unresponsive to standard cardiac therapy. An adult who received 475 mg/sq m of doxorubicin hydrochloride experienced a cardiotoxic reaction one year after the completion of therapy. The patient responded to standard cardiac therapy. Resolution of left ventricular dysfunction was verified by echocardiography and radionuclide angiocardiography.

(Arch Intern Med 1982;142:1570-1571)

Author Affiliations
From the Department of Medicine, New York University Medical Center.

Footnotes
Accepted for publication May 11, 1982.

Reprint requests to New York University Medical Center, 560 First Ave, Suite 2E, New York, NY 10016 (Dr Kronzon).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Anthracycline-Induced Cardiomyopathy: Clinical Relevance and Response to Pharmacologic Therapy
Cardinale et al.
J Am Coll Cardiol 2010;55:213-220.
ABSTRACT | FULL TEXT  

Repetitive Dobutamine Stress Echocardiography for the Prediction of Anthracycline Cardiotoxicity
Bountioukos et al.
Eur J Echocardiogr 2003;4:300-305.
ABSTRACT | FULL TEXT  

Hypothesis: troponin degradation is one of the factors responsible for deterioration of left ventricular function in heart failure
van der Laarse
Cardiovasc Res 2002;56:8-14.
ABSTRACT | FULL TEXT  

Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy
Cardinale et al.
J Am Coll Cardiol 2000;36:517-522.
ABSTRACT | FULL TEXT  

Reversibility of Severe Left Ventricular Dysfunction Due to Doxorubicin Cardiotoxicity: Report of Three Cases
SAINI et al.
ANN INTERN MED 1987;106:814-816.
ABSTRACT